Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$46.8M |
| 2 |
Zimmer Biomet
ZBH
|
+$40.5M |
| 3 |
IHS
IHS INC CL-A COM STK
IHS
|
+$22.8M |
| 4 |
Fidelity National Information Services
FIS
|
+$21.7M |
| 5 |
HOLX
Hologic
HOLX
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$116M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$99M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$25.2M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$22.2M |
| 5 |
Paychex
PAYX
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.31% |
| 2 | Industrials | 9.79% |
| 3 | Technology | 8.51% |
| 4 | Consumer Discretionary | 7.95% |
| 5 | Financials | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Assurant
AIZ
$14B
| $888K | 0.03% |
13,814
+1,214
| +10% | +$79.4K |
|
352
Pacira BioSciences
PCRX
$983M
| $881K | 0.03% |
+9,094
| New | +$885K |
|
|
EVRI
353
DELISTED
Everi Holdings
EVRI
| $879K | 0.03% |
130,236
+100,487
| +338% | +$806K |
|
354
Regions Financial
RF
$25.9B
| $879K | 0.03% |
87,561
+45,661
| +109% | +$466K |
|
355
UnitedHealth
UNH
$350B
| $878K | 0.03% |
10,185
+6,285
| +161% | +$531K |
|
356
Timken Company
TKR
$8.67B
| $875K | 0.03% |
+20,644
| New | +$950K |
|
|
IPXL
357
DELISTED
Impax Laboratories, Inc.
IPXL
| $874K | 0.03% |
36,853
+18,853
| +105% | +$483K |
|
358
Ally Financial
ALLY
$13.1B
| $873K | 0.03% |
+37,741
| New | +$901K |
|
359
Freeport-McMoran
FCX
$110B
| $871K | 0.03% |
26,667
+17,867
| +203% | +$649K |
|
360
Adeia
ADEA
$2.89B
| $868K | 0.03% |
+123,432
| New | +$861K |
|
361
Broadridge
BR
$20.8B
| $868K | 0.03% |
+20,842
| New | +$866K |
|
362
Vertex Pharmaceuticals
VRTX
$139B
| $868K | 0.03% |
7,726
+5,548
| +255% | +$528K |
|
|
INSY
363
DELISTED
Insys Therapeutics, Inc.
INSY
| $868K | 0.03% |
44,788
+9,536
| +27% | +$150K |
|
364
Huron Consulting
HURN
$2.57B
| $862K | 0.03% |
+14,143
| New | +$904K |
|
|
AD
365
Array Digital Infrastructure
AD
$3.08B
| $859K | 0.03% |
24,200
+7,800
| +48% | +$297K |
|
|
OWW
366
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $859K | 0.03% |
+109,086
| New | +$934K |
|
|
TWOU
367
DELISTED
2U Inc
TWOU
| $858K | 0.03% |
1,834
-21
| -1% | -$10K |
|
368
Centene
CNC
$32.1B
| $852K | 0.03% |
41,200
+8,800
| +27% | +$170K |
|
369
O-I Glass
OI
$1.1B
| $850K | 0.03% |
32,630
+25,777
| +376% | +$809K |
|
370
Plexus
PLXS
$6.4B
| $850K | 0.03% |
23,019
+4,780
| +26% | +$194K |
|
|
GNC
371
DELISTED
GNC Holdings, Inc.
GNC
| $849K | 0.03% |
21,913
+11,519
| +111% | +$418K |
|
372
Copa Holdings
CPA
$5.88B
| $846K | 0.03% |
7,889
+4,048
| +105% | +$539K |
|
|
BNY
373
Bank of New York Mellon
BNY
$108B
| $845K | 0.03% |
21,828
+10,728
| +97% | +$417K |
|
|
SSE
374
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $840K | 0.03% |
+35,388
| New | +$844K |
|
|
FCS
375
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $835K | 0.03% |
+53,771
| New | +$868K |
|
Similar funds
Paul Tudor Jones's Q3 2014 Portfolio in Review
As of Q3 2014, Paul Tudor Jones held 1,629 positions worth $2.77B, up 6.2% from $2.61B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Paul Tudor Jones deployed $200M of net new capital in Q3 2014, opening 486 new positions and adding to 513 existing holdings. Its largest new stake was Alibaba: 520,750 shares worth $46.3M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Apple, an estimated $116M trimmed.
- Paul Tudor Jones's largest Q3 2014 buy was Alibaba: 520,750 shares worth $46.3M.
- Paul Tudor Jones added most to Zimmer Biomet in Q3 2014, an estimated $40.5M increase.
- Paul Tudor Jones's biggest Q3 2014 reduction was Apple, cutting an estimated $116M.
- Paul Tudor Jones fully exited iShares MSCI Emerging Markets ETF in Q3 2014, selling an estimated $99M.
- Paul Tudor Jones's ten largest holdings make up 44% of its $2.77B portfolio in Q3 2014.
- Paul Tudor Jones opened 486 new positions and closed 300 in Q3 2014.
- Paul Tudor Jones's portfolio value rose 6.2% quarter-over-quarter to $2.77B.
Based on Tudor Investment Corp's 13F filing for Q3 2014, filed 14 Nov 2014.